Sociodemographic characteristics of asthma patients and accompanying comorbidities
Main Article Content
Keywords
asthma, hypertension, diabetes, obesity, hyperlipidemia, cardiovascular disease, COPD
Abstract
Objective: The aim of this study was to evaluate and compare the prevalence of comorbidities in asthmatic and non-asthmatic individuals and to compare groups based on sociodemographic variables.
Materials and Methods: This cross-sectional study used data from the 2017 National Household Health Survey (NHHS), which included 6053 individuals aged 15 years and older. The sociodemographic characteristics, behavioral risk factors, and comorbidities of the study participants were analyzed and Pearson chi-squared tests were used to assess statistical significance, and multiple logistic regression analysis was conducted to evaluate the relationships.
Results: Of the 6053 participants, 518 had asthma; 40.4% were male and 59.6% were female, and 73.2% of the asthma patients and 58.3% of the non-asthmatic individuals were females (p < 0.001). Patients with asthma had a higher prevalence of at least one comorbidity compared to non-asthmatic individuals (p < 0.001). Disease-specific analyses in patients with asthma showed higher rates of hypertension (42.9% vs. 23.9%), hyperlipidemia (35.3% vs. 19.4%), diabetes (27.8% vs. 17.7%), Chronic Obstructive Pulmonary Disease (COPD) (29.7% vs. 2.6%), cardiovascular diseases (16.0% vs. 6.1%), and obesity (56.1% vs. 36.2%) (p < 0.001). In the multiple logistic regression analysis, asthma was 14.6 times more likely in individuals with COPD, 1.6 times more likely in obese individuals, and 1.7 times more likely in those with hyperlipidemia.
Conclusion: Patients with asthma have a higher prevalence of specific comorbidities with varying sociodemographic characteristics. Further research is needed to explore the causal relationships between asthma and these comorbidities to improve disease management strategies.
References
2. Asthma [internet]. [Accessed July 10, 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma
3. Cazzola M, Segreti A, Calzetta L, Rogliani P. Comorbidities of asthma: current knowledge and future research needs. Curr Opin Pulm Med. 2013;19(1):36–41. 10.1097/MCP.0b013e32835b113a
4. De Roos EW, Lahousse L, Verhamme KMC, Braunstahl GJ, Ikram MA, In’t Veen JCCM, et al. Asthma and its comorbidities in middle-aged and older adults: The Rotterdam study. Respir Med. 2018;139:6–12. 10.1016/j.rmed.2018.04.006
5. Veenendaal M, Westerik JAM, Van Den Bemt L, Kocks JWH, Bischoff EW, Schermer TR. Age-and sex-specific prevalence of chronic comorbidity in adult patients with asthma: A real-life study. NPJ Prim Care Respir Med. 2019;29(1):14. 10.1038/s41533-019-0127-9
6. Adams RJ, Wilson DH, Taylor AW, Daly A, Tursan d’Espaignet E, Dal Grande E, et al. Coexistent chronic conditions and asthma quality of life. Chest. 2006;129(2):285–91. 10.1378/chest.129.2.285
7. Sumino K, O’Brian K, Bartle B, Au DH, Castro M, Lee TA. Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma. J Asthma. 2014; 51(3):306–14. 10.3109/02770903.2013.879881
8. Aubas C, Bourdin A, Aubas P, Gamez AS, Halimi L, Vachier I, et al. Role of comorbid conditions in asthma hospitalizations in the south of France. Allergy. 2013;68(5):637–43. 10.1111/all.12137
9. Cazzola M, Rogliani P, Ora J, Calzetta L, Matera MG. Asthma and comorbidities: Recent advances. Pol Arch Intern Med. 2022;132(4). 10.20452/pamw.16250
10. Gershon AS, Guan J, Wang C, Victor JC, To T. Describing and quantifying asthma comorbidty: A population study. PLoS ONE. 2012;7(5):e34967. 10.1371/journal.pone.0034967
11. Panek M, Mokros, Ł, Pietras T, Kuna P. The epidemiology of asthma and its comorbidities in Poland–Health problems of patients with severe asthma as evidenced in the Province of Lodz. Respir Med. 2016;112:31–8. 10.1016/j.rmed.2016.01.009
12. Wardzyńska A, Kubsik B, Kowalski ML. Comorbidities in elderly patients with asthma: Association with control of the disease and concomitant treatment. Geriatr Gerontol Int. 2015;15(7):902–9. 10.1111/ggi.12367
13. Çelebi Sözener Z, Çiftci F, Aydin Ö, Mungan D. Astımda sistemik komorbiditeler: Kontrol, ağırlık ve fenotip ile ilişkisi. Tuberk Toraks. 2018;66(4):288–96. 10.5578/tt.67629
14. World Health Organization. Regional Office for Europe & Republic of Turkey. Ministry of Health (2018). National household health survey in Turkey: Prevalence of noncommunicable disease risk factors 2017. World Health Organization. Regional Office for Europe. https://iris.who.int/handle/10665/342200
15. World Health Organization (2020), Healthy Diet [Internet]. [Accessed June 5, 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/healthy-diet
16. Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–62. 10.1136/bjsports-2020-102955
17. Coogan PF, Castro-Webb N, Yu J, O’Connor GT, Palmer JR, Rosenberg L. Active and passive smoking and the incidence of asthma in the black women’s health study. Am J Respir Crit Care Med. 2015;191(2):168–76. 10.1164/rccm.201406-1108OC
18. Skaaby T, Taylor AE, Jacobsen RK, Paternoster L, Thuesen BH, Ahluwalia TS, et al. Investigating the causal effect of smoking on hay fever and asthma: A Mendelian randomization meta-analysis in the CARTA consortium. Sci Rep. 2017;7(1):2224. 10.1038/s41598-017-01977-w
19. Thomson NC, Polosa R, Sin DD. Cigarette smoking and asthma. J Allergy Clin Immunol Pract. 2022;10(11):2783–97. 10.1016/j.jaip.2022.04.034
20. Polosa R, Knoke JD, Russo C, Piccillo G, Caponnetto P, Sarvà M, et al. Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol. 2008;121(6):1428–34. 10.1016/j.jaci.2008.02.041
21. Cazzola M, Calzetta L, Bettoncelli G, Novelli L, Cricelli C, Rogliani P. Asthma and comorbid medical illness. Eur Respir J. 2011;38(1):42–49. 10.1183/09031936.00140310
22. Cosío BG, Dacal D, Pérez De Llano L. Asthma-COPD overlap: Identification and optimal treatment. Ther Adv Respir Dis. 2018;12:1753466618805662. 10.1177/1753466618805662
23. Mekov E, Nuñez A, Sin DD, Ichinose M, Rhee CK, Maselli DJ, et al. Update on asthma-COPD overlap (ACO): A narrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1783–99. 10.2147/COPD.S312560
24. Lugogo NL, Bappanad D, Kraft M. Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta. 2011;1810(11):1120–6. 10.1016/j.bbagen.2011.09.004
25. Yildiz F, Mungan D, Gemicioglu B, Yorgancioglu A, Dursun B, Oner Erkekol F, et al. Asthma phenotypes in Turkey: A multicenter cross-sectional study in adult asthmatics; PHENOTURK study. Clin Respir J. 2017;11(2):210–23. 10.1111/crj.12326
26. Koebnick C, Fischer H, Daley MF, Ferrara A, Horberg MA, Waitzfelder B, et al. Interacting effects of obesity, race, ethnicity and sex on the incidence and control of adult-onset asthma. Allergy Asthma Clin Immunol. 2016;12(1):50. 10.1186/s13223-016-0155-8
27. Fessler MB, Massing MW, Spruell B, Jaramillo R, Draper DW, Madenspacher JH, et al. Novel relationship of serum cholesterol with asthma and wheeze in the United States. J Allergy Clin Immunol. 2009;124(5):967–74.e15. 10.1016/j.jaci.2009.08.005
28. Peng J, Huang Y. Meta-analysis of the association between asthma and serum levels of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol. Ann Allergy Asthma Immunol. 2017;118(1):61–5. 10.1016/j.anai.2016.09.447
29. Cazzola M, Calzetta L, Bettoncelli G, Cricelli C, Romeo F, Matera MG, et al. Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study. Respir Med. 2012;106(2):249–56. 10.1016/j.rmed.2011.07.021
30. Valencia-Hernández CA, Del Greco M F, Sundaram V, Portas L, Minelli C, Bloom CI. Asthma and incident coronary heart disease: An observational and Mendelian randomisation study. Eur Respir J. 2023;62(5):2301788. 10.1183/13993003.01788-2023
31. Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, et al. Asthma and incident cardiovascular disease: The atherosclerosis risk in communities study. Thorax. 2005;60(8):633–8. 10.1136/thx.2004.026484
32. Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020;12(7):3866–76. 10.21037/jtd.2020.02.47
33. Bellou V, Gogali A, Kostikas K. Asthma and tobacco smoking. J Pers Med. 2022;12(8):1231. 10.3390/jpm12081231